PL2629794T3 - Szczepionka wektorowa z herpeswirusem indyków przeciwko grypie ptaków u drobiu - Google Patents

Szczepionka wektorowa z herpeswirusem indyków przeciwko grypie ptaków u drobiu

Info

Publication number
PL2629794T3
PL2629794T3 PL11771123T PL11771123T PL2629794T3 PL 2629794 T3 PL2629794 T3 PL 2629794T3 PL 11771123 T PL11771123 T PL 11771123T PL 11771123 T PL11771123 T PL 11771123T PL 2629794 T3 PL2629794 T3 PL 2629794T3
Authority
PL
Poland
Prior art keywords
turkeys
herpesvirus
poultry
avian influenza
vaccine against
Prior art date
Application number
PL11771123T
Other languages
English (en)
Inventor
Paulus Jacobus Antonius Sondermeijer
Iwan Verstegen
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of PL2629794T3 publication Critical patent/PL2629794T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C12N15/869—Herpesviral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/60—Vector systems having a special element relevant for transcription from viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
PL11771123T 2010-10-18 2011-10-17 Szczepionka wektorowa z herpeswirusem indyków przeciwko grypie ptaków u drobiu PL2629794T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP10187948 2010-10-18
US40772410P 2010-10-28 2010-10-28
PCT/EP2011/068073 WO2012052384A1 (en) 2010-10-18 2011-10-17 Herpesvirus of turkeys vectored vaccine against avian influenza in poultry
EP11771123.4A EP2629794B1 (en) 2010-10-18 2011-10-17 Herpesvirus of turkeys vectored vaccine against avian influenza in poultry

Publications (1)

Publication Number Publication Date
PL2629794T3 true PL2629794T3 (pl) 2017-10-31

Family

ID=43587599

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11771123T PL2629794T3 (pl) 2010-10-18 2011-10-17 Szczepionka wektorowa z herpeswirusem indyków przeciwko grypie ptaków u drobiu

Country Status (8)

Country Link
US (1) US8986987B2 (pl)
EP (1) EP2629794B1 (pl)
CN (1) CN103370079B (pl)
ES (1) ES2635019T3 (pl)
HU (1) HUE033739T2 (pl)
MX (1) MX344069B (pl)
PL (1) PL2629794T3 (pl)
WO (1) WO2012052384A1 (pl)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103667351B (zh) * 2012-09-10 2017-01-25 中国农业科学院哈尔滨兽医研究所 以鸭病毒性肠炎病毒疫苗株为载体的重组病毒疫苗在鸡形目禽类中的应用
US10398769B2 (en) 2013-08-06 2019-09-03 The Trustees Of The University Of Pennsylvania Influenza nucleic acid molecules and vaccines made therefrom
CN106031793B (zh) * 2015-03-13 2020-12-01 普莱柯生物工程股份有限公司 一种活疫苗及其制备方法和应用
MX2018001815A (es) * 2015-08-10 2018-09-06 Texas A & M Univ Sys Vacunas de herpesvirus de pavo recombiante y uso de las mismas.
JP7046014B2 (ja) 2016-06-17 2022-04-01 インターベット インターナショナル ベー． フェー． 伝染性喉頭気管炎ウイルスおよび伝染性ファブリキウス嚢病ウイルスの抗原をコードする組換え非病原性マレック病ウイルスコンストラクト
JOP20190088A1 (ar) * 2016-10-21 2019-04-21 Us Agriculture نواقل مؤتلفة للتعبير عن مولدات مضاد فيروس انفلونزا الطيور و استخداماتها
CN106399267A (zh) * 2016-10-28 2017-02-15 扬州大学 表达H7N9亚型禽流感病毒血凝素蛋白的重组火鸡疱疹病毒株rHOH及构建方法
CN106497893A (zh) * 2016-10-28 2017-03-15 扬州大学 表达H7N9亚型禽流感病毒嵌合型血凝素蛋白的重组火鸡疱疹病毒株rHMW及构建方法
CN107296956A (zh) * 2017-06-29 2017-10-27 青岛易邦生物工程有限公司 一种基因重组活载体疫苗
CN109666656A (zh) * 2019-01-23 2019-04-23 北京市农林科学院 一种纯化重组鸡传染性法氏囊病毒vp2基因的马立克氏病病毒cvi988株的方法
CN110205308A (zh) * 2019-05-24 2019-09-06 华南农业大学 一种表达ha基因的重组火鸡疱疹病毒及其应用
MX2022007579A (es) * 2019-12-20 2022-07-19 Intervet Int Bv Vacuna de vector hvt multivalente.
EP4210740A1 (en) 2020-09-07 2023-07-19 Intervet International B.V. Ha stem vaccine for ha antibody-positive targets
WO2022136623A1 (en) 2020-12-24 2022-06-30 Intervet International B.V. Multivalent hvt vector vaccine
EP4370150A1 (en) 2021-07-13 2024-05-22 Intervet International B.V. Overcoming antibody-interference in avians
US20250352642A1 (en) 2022-05-05 2025-11-20 Intervet Inc. New multivalent hvt vector vaccine

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5961982A (en) 1985-09-06 1999-10-05 Syntro Corporation Recombinant herpesvirus of turkeys and uses thereof
US5928648A (en) * 1985-09-06 1999-07-27 Syntro Corporation Recombinant herpesvirus of turkeys and uses thereof
ATE342996T1 (de) 1986-01-27 2006-11-15 Schering Plough Ltd Attenuierte herpesviren, herpesviren die eine aminosäuresequenz kodierende fremde dna enthalten,und diese enthaltende impfstoffe
US5731188A (en) * 1986-11-20 1998-03-24 Syntro Corporation Recombinant equine herpesviruses
DE69015222T2 (de) 1989-02-04 1995-05-04 Akzo Nv Tocole als Impfstoffadjuvans.
US5919461A (en) * 1989-10-18 1999-07-06 Akzo Nobel N.V. Nonpathogenic infectious bursal disease virus and vaccine
ES2070997T3 (es) * 1989-12-04 1995-06-16 Akzo Nobel Nv Virus de herpes recombinante de pavos y vacunas vector vivas derivadas de los mismos.
US5690939A (en) * 1991-05-14 1997-11-25 Akzo Nobel N.V. Recombinant vaccine against marek's disease
ZA923041B (en) * 1991-05-14 1993-04-28 Akzo Nv Recombinant vaccine against marek's disease
US5853733A (en) * 1993-02-26 1998-12-29 Syntro Corporation Recombinant herpesvirus of turkeys and uses thereof
US6913751B2 (en) * 1992-06-12 2005-07-05 Schering-Plough Veterinary Corporation Recombinant avian herpesvirus useful in vaccine production
US6183753B1 (en) * 1994-08-09 2001-02-06 Schering-Plough Veterinary Corp. Recombinant chimeric virus and uses thereof
US5741696A (en) * 1992-08-07 1998-04-21 Syntro Corporation Recombinant equine herpesviruses
US6984728B2 (en) * 1993-09-24 2006-01-10 Schering Corporation Recombinant infectious laryngotracheitis virus and uses thereof
DK0775746T3 (da) 1995-07-03 2006-04-03 Akzo Nobel Nv Vaccine mod fjerkræcoccidiose
JPH11509099A (ja) * 1995-07-07 1999-08-17 日本ゼオン株式会社 マレック病ウイルス遺伝子およびマレック病に対する防御のためのワクチンにおけるそれらの使用
EP0794259B1 (en) 1996-03-04 2004-10-06 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Process for producing a saccharide composition containing trehalulose.
EP1100925B1 (en) * 1998-07-31 2006-01-18 Akzo Nobel N.V. Attenuated equine herpesvirus
US6458363B1 (en) 1998-12-21 2002-10-01 Akzo Nobel N.V. Method to produce inactivated w/o emulsion adjuvated vaccines
US6299882B1 (en) * 1999-04-09 2001-10-09 Schering Corporation UL54.5 of Marek's disease virus (MDV)
WO2001005988A1 (en) 1999-07-16 2001-01-25 Merial Select, Inc Live recombinant vaccine against avian leukosis virus using a marek's disease virus (mdv) virus as vector
US7314715B2 (en) * 2001-06-14 2008-01-01 Schering-Plough Animal Health Corporation Recombinant avian herpesvirus useful in vaccine production
ES2620789T3 (es) * 2005-08-15 2017-06-29 Altimmune Inc. Inmunización de aves por administración de vacunas con vectores no replicantes
US20080241188A1 (en) 2007-03-30 2008-10-02 Zeon Corporation Turkey herpesvirus vectored recombinant containing avian influenza genes
EP2291397A1 (en) 2008-06-23 2011-03-09 Intervet International BV Recombinant herpesvirus of turkeys encoding for interleukin-12
CN102271704A (zh) * 2008-11-28 2011-12-07 梅里亚有限公司 重组禽流感疫苗及其用途
CN102405058B (zh) 2009-04-15 2015-11-25 法国诗华大药厂 用于免疫接种水禽物种的重组禽疱疹病毒载体和疫苗

Also Published As

Publication number Publication date
MX344069B (es) 2016-12-02
HUE033739T2 (en) 2018-01-29
US8986987B2 (en) 2015-03-24
EP2629794A1 (en) 2013-08-28
EP2629794B1 (en) 2017-06-07
CN103370079B (zh) 2016-08-10
ES2635019T3 (es) 2017-10-02
US20130230556A1 (en) 2013-09-05
WO2012052384A1 (en) 2012-04-26
CN103370079A (zh) 2013-10-23
MX2013004303A (es) 2013-05-30

Similar Documents

Publication Publication Date Title
IL261204A (en) Influenza virus vaccines and their use
IL262123A (en) Influenza virus vaccines and uses thereof
ZA201404797B (en) Influenza virus vaccines and uses thereof
PL2611460T3 (pl) Szczepionki przeciw herpeswirusom przenoszone z pomocą wirusa choroby newcastle
EP2552479A4 (en) INFLUENZA VIRUS VACCINES AND USES THEREOF
IL239284A0 (en) Nasal flu vaccine compound
PL3073959T3 (pl) Zespól szczepiący do podawania szczepionki do młodej kury
ZA201406979B (en) Multivalent recombinant avian herpes viruses and vaccines for immunizing avian species
SG11201401998VA (en) Vaccines directed against human enteroviruses
IL240504A0 (en) Combined vaccine for respiratory syncytial virus and influenza
ZA201300395B (en) Influenza vaccine
SG11201404147YA (en) Computationally optimized broadly reactive antigens for human and avian h5n1 influenza
IL236270B (en) Cationic lipid vaccine compositions and methods of use
HUE051711T2 (hu) Influenzavakcina antigénjeinek koncentrálása liofilizálás nélkül
HUE036110T2 (hu) Legyengített sertésinfluenza vakcinák és eljárások azok elõállítására és alkalmazására
SG11201500007WA (en) Benzodioxole derivative and preparation method and use thereof
EP2678361A4 (en) COMPOSITIONS WITH IMPROVED IMMUNOGENICITY AND / OR REDUCED REACTIVITY AND METHOD OF USE THEREOF
EP2839840A4 (en) RECOMBINANT TRUMPLANT VACCINE AGAINST HUMAN FLUID
PL3415643T3 (pl) Wytwarzanie żywych szczepionek
ZA201307570B (en) Use of dithine-tetracarboximides as bird repellent
GB201003332D0 (en) Efficient preparation of combination vaccines
HK1197804A (en) Herpes virus vaccine and methods of use
GB201005518D0 (en) Preservation of alum-adjuvanted vaccines